
Chuck Y. Mah
Examiner (ID: 13799, Phone: (571)272-7059 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3209, 3205, 3677, 3626, 3676 |
| Total Applications | 4008 |
| Issued Applications | 3305 |
| Pending Applications | 173 |
| Abandoned Applications | 569 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12125055
[patent_doc_number] => 20180008641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Use of MicroRNA 375 in Augmenting Stem Cell Based and Endogenous Ischemic Tissue Repair'
[patent_app_type] => utility
[patent_app_number] => 15/527767
[patent_app_country] => US
[patent_app_date] => 2015-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23338
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527767 | Use of MicroRNA 375 in Augmenting Stem Cell Based and Endogenous Ischemic Tissue Repair | Nov 17, 2015 | Abandoned |
Array
(
[id] => 12219477
[patent_doc_number] => 20180057837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'DNA PLASMID, CODING HNP-1, OR HNP-2, OR HNP-3, BACTERIAL PRODUCER, ANALGESIC AGENT (VARIANTS)'
[patent_app_type] => utility
[patent_app_number] => 15/524782
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10878
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524782 | DNA PLASMID, CODING HNP-1, OR HNP-2, OR HNP-3, BACTERIAL PRODUCER, ANALGESIC AGENT (VARIANTS) | Nov 9, 2015 | Abandoned |
Array
(
[id] => 18793928
[patent_doc_number] => 11827680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Compounds and methods of treating usher syndrome III
[patent_app_type] => utility
[patent_app_number] => 15/525270
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12247
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525270 | Compounds and methods of treating usher syndrome III | Nov 5, 2015 | Issued |
Array
(
[id] => 10784398
[patent_doc_number] => 20160130554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Reprogramming Mesenchymal Stromal Cells Into Hematopoietic Cells'
[patent_app_type] => utility
[patent_app_number] => 14/931899
[patent_app_country] => US
[patent_app_date] => 2015-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29194
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14931899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/931899 | Reprogramming Mesenchymal Stromal Cells Into Hematopoietic Cells | Nov 3, 2015 | Abandoned |
Array
(
[id] => 14132759
[patent_doc_number] => 20190100769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => MASSIVELY PARALLEL COMBINATORIAL GENETICS FOR CRISPR
[patent_app_type] => utility
[patent_app_number] => 15/521931
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521931 | MASSIVELY PARALLEL COMBINATORIAL GENETICS FOR CRISPR | Oct 29, 2015 | Abandoned |
Array
(
[id] => 10767848
[patent_doc_number] => 20160114004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'ROLE OF A CLUSTER OF LONG NONCODING RNA TRANSCRIPTS IN PROTECTING THE HEART FROM PATHOLOGICAL HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 14/884827
[patent_app_country] => US
[patent_app_date] => 2015-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 27184
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14884827
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/884827 | Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy | Oct 15, 2015 | Issued |
Array
(
[id] => 11218838
[patent_doc_number] => 09447164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Engineered nucleic acids and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/878286
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 37592
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14878286
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/878286 | Engineered nucleic acids and methods of use thereof | Oct 7, 2015 | Issued |
Array
(
[id] => 11987797
[patent_doc_number] => 20170291953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'CAR EXPRESSION VECTOR AND CAR-EXPRESSING T CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/513870
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14704
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/513870 | Car expression vector and car-expressing T cells | Oct 5, 2015 | Issued |
Array
(
[id] => 14171723
[patent_doc_number] => 10259857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Method for augmenting vision in persons suffering from photoreceptor cell degeneration
[patent_app_type] => utility
[patent_app_number] => 14/875174
[patent_app_country] => US
[patent_app_date] => 2015-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8066
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/875174 | Method for augmenting vision in persons suffering from photoreceptor cell degeneration | Oct 4, 2015 | Issued |
Array
(
[id] => 11053328
[patent_doc_number] => 20160250290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/867866
[patent_app_country] => US
[patent_app_date] => 2015-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4631
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14867866
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/867866 | GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE | Sep 27, 2015 | Abandoned |
Array
(
[id] => 11827703
[patent_doc_number] => 09724430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/864265
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 51315
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14864265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/864265 | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof | Sep 23, 2015 | Issued |
Array
(
[id] => 10750909
[patent_doc_number] => 20160097060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'Production of Vectors for Non-Dividing Host Cells'
[patent_app_type] => utility
[patent_app_number] => 14/862731
[patent_app_country] => US
[patent_app_date] => 2015-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3414
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14862731
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/862731 | Production of Vectors for Non-Dividing Host Cells | Sep 22, 2015 | Abandoned |
Array
(
[id] => 10489783
[patent_doc_number] => 20150374803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/850292
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12228
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14850292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/850292 | ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF USE THEREOF | Sep 9, 2015 | Abandoned |
Array
(
[id] => 11969847
[patent_doc_number] => 20170274001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'Compositions and Methods for Increasing Red Blood Cells'
[patent_app_type] => utility
[patent_app_number] => 15/507151
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21636
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507151
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507151 | Compositions and Methods for Increasing Red Blood Cells | Sep 7, 2015 | Abandoned |
Array
(
[id] => 10481925
[patent_doc_number] => 20150366942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE'
[patent_app_type] => utility
[patent_app_number] => 14/842870
[patent_app_country] => US
[patent_app_date] => 2015-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7670
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842870
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842870 | GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE | Sep 1, 2015 | Abandoned |
Array
(
[id] => 10980351
[patent_doc_number] => 20160177295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 14/839886
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22448
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14839886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/839886 | RNA with a combination of unmodified and modified nucleotides for protein expression | Aug 27, 2015 | Issued |
Array
(
[id] => 11061011
[patent_doc_number] => 20160257973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHODS FOR INCREASING CAS9-MEDIATED ENGINEERING EFFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 14/836753
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31151
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836753
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/836753 | Methods for increasing CAS9-mediated engineering efficiency | Aug 25, 2015 | Issued |
Array
(
[id] => 11992430
[patent_doc_number] => 20170296585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'IDENTIFICATION AND ISOLATION OF MULTIPOTENT CELLS FROM NON-OSTEOCHONDRAL MESENCHYMAL TISSUE'
[patent_app_type] => utility
[patent_app_number] => 14/834006
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 12140
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834006
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834006 | Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue | Aug 23, 2015 | Issued |
Array
(
[id] => 13841223
[patent_doc_number] => 20190024096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => PROCESS FOR THE IN VIVO PRODUCTION OF RNA IN A HOST CELL
[patent_app_type] => utility
[patent_app_number] => 15/750644
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750644
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750644 | PROCESS FOR THE IN VIVO PRODUCTION OF RNA IN A HOST CELL | Aug 6, 2015 | Abandoned |
Array
(
[id] => 11850351
[patent_doc_number] => 20170224843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'GENOME EDITING FOR THE TREATMENT OF HUNTINGTON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/501965
[patent_app_country] => US
[patent_app_date] => 2015-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21123
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501965 | GENOME EDITING FOR THE TREATMENT OF HUNTINGTON'S DISEASE | Aug 3, 2015 | Abandoned |